Trials / Completed
CompletedNCT06518798
Feasibility and Preliminary Effects of Fasting-Mimicking Diet in Asian Americans With Prediabetes
Pilot Study on Fasting-Mimicking Diet in Asian Americans With Prediabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of California, Irvine · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot study to determine the feasibility of studying the Fasting-Mimicking Diet (FMD), a dietary approach that involves the consumption of a specifically formulated, calorie-restricted nutrition regimen with a customized macronutrient composition, ratio, and quantity over a 5- day period, on a larger scale in Asian Americans with prediabetes and to examine the preliminary effects of the diet in study participants. The main questions the study aims to answer are: 1. What are the recruitment, adherence, and attrition rates of eligible participants into the study? 2. Does one FMD cycle result in changes in fasting blood glucose levels and physical measurements in study participants? Participants will be asked to undergo one cycle of FMD (for 5 days), fill out surveys, and come in for a pre-FMD and post-FMD study visit, during which physical measurements and fasting blood glucose and ketone levels will be measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Fasting Mimicking Diet | Participants will be instructed to follow their usual diet except for 5 days when they eat the foods in the FMD kit. The FMD consists of a blend of 100% plant based nutrients generally regarded as safe. One FMD kit provides for the replacement of the normal diet with plant products for five consecutive days. The formulation of these products was based on studies carried out at the Longevity Institute of the University of Southern California, led by Dr. Valter Longo and his collaborators over several decades of research. |
Timeline
- Start date
- 2024-08-12
- Primary completion
- 2025-05-09
- Completion
- 2025-05-09
- First posted
- 2024-07-24
- Last updated
- 2025-09-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06518798. Inclusion in this directory is not an endorsement.